Literature DB >> 24129771

Inhibition of presynaptic neurotoxins in taipan venom by suramin.

Sanjaya Kuruppu1, Janeyuth Chaisakul, A Ian Smith, Wayne C Hodgson.   

Abstract

Taipans are amongst the most venomous snakes in the world, and neurotoxicity is a major life-threatening symptom of envenoming by these snakes. Three species of taipans exist, and the venom from each species contains a presynaptic neurotoxin which accounts for much of the neurotoxicity observed following human envenoming. The high cost of antivenom used to treat neurotoxicity has resulted in the need to develop alternative but effective therapies. Therefore, in this study, we examined the ability of the P2Y receptor antagonist suramin to prevent the in vitro neurotoxic effects of the three presynaptic neurotoxins in taipan venoms: taipoxin, paradoxin and cannitoxin. Toxins were purchased from commercial sources or purified in house, using multiple steps of gel filtration chromatography. All three toxins (11 nM) inhibited nerve-mediated twitches in the chick biventer cervicis nerve-muscle preparation within 300 min. The presence of suramin (0.3 mM) completely blocked the taipoxin and cannitoxin-mediated inhibition of nerve-mediated twitches within the course of the experiment (P < 0.0001). However, paradoxin induced a 32 % decrease in twitch height even in the presence of suramin within 360 min. This was significantly different compared to toxin alone (P < 0.0001). We also examined the effect of suramin on the neurotoxic effects of textilotoxin and the products of phospholipase A2 action. Each toxin alone or in the presence of suramin failed to inhibit the responses to exogenous agonists ACh, CCh or KCl. Our results warrant clinical studies aimed determining the efficacy of suramin in preventing the onset of neurotoxicity following taipan envenoming.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129771     DOI: 10.1007/s12640-013-9426-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  22 in total

1.  Comparison of two highly toxic Australian snake venoms: the taipan (Oxyuranus S. scutellatus) and the fierce snake (Parademansia microlepidotus).

Authors:  J Fohlman
Journal:  Toxicon       Date:  1979       Impact factor: 3.033

2.  Presynaptic toxicity of the histidine-modified, phospholipase A2-inactive, beta-bungarotoxin, crotoxin and notexin.

Authors:  C C Chang; M J Su
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

3.  Taipoxin, an extremely potent presynaptic snake venom neurotoxin. Elucidation of the primary structure of the acidic carbohydrate-containing taipoxin-subunit, a prophospholipase homolog.

Authors:  J Fohlman; P Lind; D Eaker
Journal:  FEBS Lett       Date:  1977-12-15       Impact factor: 4.124

4.  Neuromuscular effects of Papuan Taipan snake venom.

Authors:  S Connolly; A J Trevett; N C Nwokolo; D G Lalloo; S Naraqi; D Mantle; I S Schofield; P R Fawcett; J B Harris; D A Warrell
Journal:  Ann Neurol       Date:  1995-12       Impact factor: 10.422

5.  Suramin inhibits the toxic effects of presynaptic neurotoxins at the mouse motor nerve terminals.

Authors:  S Y Lin-Shiau; M J Lin
Journal:  Eur J Pharmacol       Date:  1999-10-08       Impact factor: 4.432

6.  Potassium channel blocking actions of beta-bungarotoxin and related toxins on mouse and frog motor nerve terminals.

Authors:  E G Rowan; A L Harvey
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

7.  The facilitatory actions of snake venom phospholipase A(2) neurotoxins at the neuromuscular junction are not mediated through voltage-gated K(+) channels.

Authors:  B Fathi H; E G Rowan; A L Harvey
Journal:  Toxicon       Date:  2001-12       Impact factor: 3.033

Review 8.  Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective.

Authors:  Sanjaya Kuruppu; A Ian Smith; Geoffrey K Isbister; Wayne C Hodgson
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

9.  How do presynaptic PLA2 neurotoxins block nerve terminals?

Authors:  C Montecucco; O Rossetto
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

10.  Suramin inhibits the early effects of PLA(2) neurotoxins at mouse neuromuscular junctions: A twitch tension study.

Authors:  Behrooz Fathi; Alan L Harvey; Edward G Rowan
Journal:  J Venom Res       Date:  2011-01-02
View more
  1 in total

Review 1.  100 Years of Suramin.

Authors:  Natalie Wiedemar; Dennis A Hauser; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.